Placebocontrolled Preclinical Evaluation of Safety/Toxicology of induced pluripotent stem cells (iPSCs)-derived mesenchymal stem cells (MSCs) in clinically relevant ovine model of Severe Acute Lung Injury

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/20 → 12/31/22

Funding

  • Citius Pharmaceuticals, Inc: $736,014.00